Atossa Therapeutics
ATOS
13 hedge funds and large institutions have $1.18M invested in Atossa Therapeutics in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
268% more capital invested
Capital invested by funds: $322K → $1.18M (+$861K)
95% more call options, than puts
Call options by funds: $78K | Put options by funds: $40K
30% more funds holding
Funds holding: 10 → 13 (+3)
0.05% more ownership
Funds ownership: 0.18% → 0.23% (+0.05%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$169K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.97K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.76K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.67K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
+$248 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$4.26K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$4K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$922 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $459K | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $341K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $271K | +$169K | +4,757 | New |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $51.7K | -$922 | -26 | -3% |
|
|
5
Northern Trust
Chicago,
Illinois
| $41K | -$4.26K | -120 | -14% |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | +$3.76K | +106 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $6K | +$3.97K | +112 | New |
|
|
8
Group One Trading
Chicago,
Illinois
| $5K | +$1.67K | +47 | +142% |
|
9
BlackRock
New York
| $2K | – | – | – |
|
|
10
Victory Capital Management
San Antonio,
Texas
| – | -$4K | -207 | Closed |
|
|
CG
11
Cutler Group
San Francisco,
California
| – | +$248 | +7 | New |
|
ATOS Hedge Fund Activity: Q2 2020 in Review
13 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Atossa Therapeutics (ATOS) for Q2 2020, worth a combined $1.18M — up 268% from $322K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ATOS positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $169K. The largest seller was Northern Trust, cutting an estimated $4.26K.
- 13 institutional investors held Atossa Therapeutics (ATOS) as of Q2 2020, up from 10 in Q1 2020.
- Funds reported $1.18M of Atossa Therapeutics stock for Q2 2020, up 268% quarter-over-quarter.
- 4 funds opened new Atossa Therapeutics positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest Atossa Therapeutics buyer in Q2 2020 was Susquehanna International Group, an estimated $169K added.
- The largest Atossa Therapeutics seller in Q2 2020 was Northern Trust, an estimated $4.26K sold.
Based on aggregated 13F filings for Q2 2020.